Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance Study for Adolescent Depression
NCT00508859Phase 4Completed
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Jul 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing Sertraline Maintenance with Placebo Maintenance (2 arms). Primary endpoint: Recurrence of depression at 52 weeks. Started Jul 1997; status: completed.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00508859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00508859.